Pagnesi, Matteo
 Distribuzione geografica
Continente #
AS - Asia 476
EU - Europa 371
NA - Nord America 364
AF - Africa 4
SA - Sud America 3
OC - Oceania 2
Totale 1.220
Nazione #
US - Stati Uniti d'America 362
SG - Singapore 185
IT - Italia 170
HK - Hong Kong 133
TR - Turchia 74
DE - Germania 67
CN - Cina 64
FI - Finlandia 50
IE - Irlanda 25
GB - Regno Unito 24
FR - Francia 10
CZ - Repubblica Ceca 7
JP - Giappone 5
IN - India 4
ES - Italia 3
UA - Ucraina 3
CA - Canada 2
ID - Indonesia 2
IR - Iran 2
KZ - Kazakistan 2
NL - Olanda 2
NZ - Nuova Zelanda 2
PE - Perù 2
PL - Polonia 2
TN - Tunisia 2
VN - Vietnam 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
SE - Svezia 1
Totale 1.220
Città #
Singapore 148
Hong Kong 130
Istanbul 73
Chandler 67
New York 50
Romola 44
Beijing 34
Helsinki 33
Dublin 25
Princeton 24
Shanghai 20
Milan 18
Munich 17
Ashburn 15
Lappeenranta 15
Brescia 14
London 11
Rome 7
Brno 6
Strasbourg 6
West Jordan 6
Padova 5
Curno 4
Frankfurt am Main 4
Kilburn 4
Prineville 4
Springfield 4
Venice 4
Washington 4
Airola 3
Azzano San Paolo 3
Lviv 3
Matera 3
Nantes 3
Potsdam 3
Tokyo 3
Acton 2
Bagnoli del Trigno 2
Bari 2
Berlin 2
Bernareggio 2
Boardman 2
Calcinato 2
Cape Town 2
Castrezzato 2
Christchurch 2
Costa Masnaga 2
Espoo 2
Fairfield 2
Fort Worth 2
Gavardo 2
Gijón 2
Guangzhou 2
Ho Chi Minh City 2
Leipzig 2
Lima 2
Lodz 2
Los Angeles 2
Montesilvano Marina 2
North Bergen 2
Pisogne 2
Prescot 2
Sandigliano 2
Sidoarjo 2
Toscolano-Maderno 2
Tunis 2
Verbania 2
Agropoli 1
Almaty 1
Baku 1
Bishkek 1
Brembate di Sopra 1
Central 1
Coimbatore 1
Colombo 1
Des Moines 1
Fornovo San Giovanni 1
Gambassi Terme 1
Hounslow 1
Kashan 1
Lariano 1
Luxembourg 1
Madrid 1
Miami 1
Montreal 1
Nanjing 1
Newark 1
Oklahoma City 1
Olomouc 1
Patna 1
Pontedera 1
Pune 1
Salò 1
San Diego 1
San Francisco 1
Santa Clara 1
Santiago 1
Sarajevo 1
Seattle 1
Sofia 1
Totale 912
Nome #
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 40
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 38
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 34
Vericiguat for Heart Failure with Reduced Ejection Fraction 32
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 31
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 28
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 25
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 25
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 25
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 25
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 25
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 24
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 24
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 23
Combined pre- and post-capillary pulmonary hypertension in left heart disease 22
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 21
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 21
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 21
March 2021 at a glance: focus on epidemiology, prevention and COVID-19 20
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 20
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy 20
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 19
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 19
2024 update in heart failure 18
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 18
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 17
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 17
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 17
High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? 17
Ejection fraction in heart failure: just become Emperor's new clothes? 17
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 17
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 16
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 16
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 15
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 15
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 15
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 14
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 14
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 14
Heart failure: an update from the last years and a look at the near future 14
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope 14
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 14
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 14
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 14
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 13
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 13
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 13
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 13
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 13
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 13
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 13
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 12
Right ventricular thrombosis: from a case report to pathophysiology mechanisms and current treatment options 12
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 12
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 11
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 11
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 11
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 10
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 10
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 10
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 10
NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial 10
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF 10
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 10
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 10
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? 9
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 9
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 9
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 9
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 8
Impact of malnutrition in patients with severe heart failure 8
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 8
Prognostic role of mitral regurgitation in patients with advanced heart failure 8
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial 7
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 7
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial 7
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 7
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 6
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 6
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 6
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 6
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 5
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 5
Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study 4
Totale 1.283
Categoria #
all - tutte 20.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 0 2 1 2 0 2 0 3 26
2022/2023206 23 21 4 6 15 56 2 16 26 1 13 23
2023/2024638 27 11 52 33 30 71 42 17 150 21 51 133
2024/2025403 13 22 81 155 132 0 0 0 0 0 0 0
Totale 1.283